Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy

Background. Parkinson's disease (PD) remains a clinical diagnosis and biomarkers are needed to detect the disease as early as possible. Genetically determined PD provides an opportunity for studying metabolic differences in connection with disease development. Objectives. To study the levels of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Parkinsons Dis
Asıl Yazarlar: Aasly, Jan O., Sæther, Oddbjørn, Johansen, Krisztina K., Bathen, Tone F., Giskeødegård, Guro F., White, Linda R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556333/
https://ncbi.nlm.nih.gov/pubmed/26357583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/264896
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller